Program

Girish N. Nadkarni, M.D.
Irene and Dr. Arthur M. Fishberg Professor of Medicine, Icahn School of Medicine at Mount Sinai

AI-guided detection of under-recognized cardiomyopathies on point-of-care cardiac ultrasonography
9-10 a.m., Introduction and Q&A by Jake Chen, Ph.D.

Girish N. Nadkarni, MD, MPH, is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the System Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Director of the Mount Sinai Clinical Intelligence Center (MSCIC) and the Director of Charles Bronfman Institute for Personalized Medicine.

Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.

Dr. Nadkarni has authored more than 240 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19. He has several patents and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award, the Deal of the Year award from Mount Sinai Innovation Partners, the Carl Nacht Memorial Lecture, and the Rising Star Award from ANIO.

Michael Synder, Ph.D.
Stanford W. Ascherman Professor, Department of Genetics
Director, Stanford Center for Genomics and Personalized Medicine
School of Medicine, Stanford University

Disrupting healthcare using deep data and remote monitoring
1-2 p.m., Introduction and Q&A by Javier Neyra, M.D., MS

As a pioneer of Precision Medicine, Dr. Michael Snyder has invented many technologies enabling the 21st century of healthcare, including systems biology, RNA sequencing, and protein chip. Dr. Snyder has initiated the Big Data approach to healthcare through his work using omics to detect early-stage disease, including wearables to detect infectious diseases like COVID-19, and at-home microsampling to measure hundreds of molecules from a single drop of blood. He is the first researcher to gather petabytes of data on individuals, which is 1 million – 1 trillion times more data than the average clinician collects. He has published over 900 papers and is one of the most cited scientists. In terms of commercial success, Dr. Snyder has co-founded 17 companies (including 2 unicorns) with a combined enterprise value of over $6 billion.